Todralazine (hydrochloride)
Todralazine hydrochloride (Ecarazine hydrochloride) is an anti-hypertensive agent, acts as a β2AR blocker, with antioxidant and free radical scavenging activity[1].
Product Specifications
CAS Number
[3778-76-5]
Product Name Alternative
Ecarazine (hydrochloride)
UNSPSC
12352005
Hazard Statement
H302-H312-H332
Target
Adrenergic Receptor
Type
Reference compound
Related Pathways
GPCR/G Protein; Neuronal Signaling
Applications
Neuroscience-Neuromodulation
Field of Research
Cardiovascular Disease; Endocrinology
Assay Protocol
https://www.medchemexpress.com/todralazine-hydrochloride.html
Purity
99.87
Solubility
DMSO : 125 mg/mL (ultrasonic) |H2O : 14.29 mg/mL (ultrasonic)
Smiles
O=C(NNC1=NN=CC2=C1C=CC=C2)OCC.[H]Cl
Molecular Formula
C11H13ClN4O2
Molecular Weight
268.70
Precautions
P261-P264-P270-P271-P280-P302+P352-P304+P340-P330-P362+P364-P501
References & Citations
Shipping Conditions
Blue Ice
Storage Conditions
-20°C (Powder, sealed storage, away from moisture)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
β adrenergic receptor
Available Sizes
Explore Other Products
Browse additional items from our catalog
KAAG1 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 2)
TTBK1, ID (TTBK1, BDTK, KIAA1855, Tau-tubulin kinase 1, Brain-derived tau kinase) (AP)
TTBK1, ID (TTBK1, BDTK, KIAA1855, Tau-tubulin kinase 1, Brain-derived tau kinase) (AP)